Frontiers in Pharmacology (Dec 2022)
Corrigendum: Danshensu methyl ester enhances autophagy to attenuate pulmonary fibrosis by targeting lncIAPF–HuR complex
- Qi Zhu,
- Jing Wang,
- Yunxia Ji,
- Jianlin Luan,
- Dayong Yue,
- Weili Liu,
- Hongbo Li,
- Jinjin Zhang,
- Guiwu Qu,
- Changjun Lv,
- Xiaodong Song
Affiliations
- Qi Zhu
- Department of Cellular and Genetic Medicine, School of Pharmaceutical Sciences, Binzhou Medical University, Yantai, China
- Jing Wang
- Department of Cellular and Genetic Medicine, School of Pharmaceutical Sciences, Binzhou Medical University, Yantai, China
- Yunxia Ji
- Department of Respiratory and Critical Care Medicine, Binzhou Medical University Hospital, Binzhou Medical University, Binzhou, China
- Jianlin Luan
- Department of Cellular and Genetic Medicine, School of Pharmaceutical Sciences, Binzhou Medical University, Yantai, China
- Dayong Yue
- Department of Cellular and Genetic Medicine, School of Pharmaceutical Sciences, Binzhou Medical University, Yantai, China
- Weili Liu
- Department of Respiratory and Critical Care Medicine, Binzhou Medical University Hospital, Binzhou Medical University, Binzhou, China
- Hongbo Li
- Department of Respiratory and Critical Care Medicine, Binzhou Medical University Hospital, Binzhou Medical University, Binzhou, China
- Jinjin Zhang
- Medical Research Center, Binzhou Medical University, Yantai, China
- Guiwu Qu
- School of Gerontology, Binzhou Medical University, Yantai, China
- Changjun Lv
- Department of Respiratory and Critical Care Medicine, Binzhou Medical University Hospital, Binzhou Medical University, Binzhou, China
- Xiaodong Song
- Department of Cellular and Genetic Medicine, School of Pharmaceutical Sciences, Binzhou Medical University, Yantai, China
- DOI
- https://doi.org/10.3389/fphar.2022.1086927
- Journal volume & issue
-
Vol. 13
Abstract
No abstracts available.Keywords
